naftopidil has been researched along with Nervous System Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, M | 1 |
| Homma, Y | 1 |
| Araki, I | 1 |
| Kakizaki, H | 1 |
| Yamanishi, T | 1 |
| Yokota, T | 1 |
| Gotoh, M | 1 |
| Igawa, Y | 1 |
| Seki, N | 1 |
| Takei, M | 1 |
| Yoshida, M | 1 |
| Sugaya, K | 1 |
| Nishizawa, O | 1 |
1 trial available for naftopidil and Nervous System Disorders
| Article | Year |
|---|---|
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Epidemiologic Methods; Fema | 2011 |